- Home
- MHH vs PLRX Comparison
MHH vs PLRX Comparison
Compare MHH & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- PLRX
- Stock Information
- Founded
- MHH 1986
- PLRX 2015
- Country
- MHH United States
- PLRX United States
- Employees
- MHH N/A
- PLRX N/A
- Industry
- MHH Professional Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- PLRX Health Care
- Exchange
- MHH Nasdaq
- PLRX Nasdaq
- Market Cap
- MHH 86.6M
- PLRX 89.0M
- IPO Year
- MHH N/A
- PLRX 2020
- Fundamental
- Price
- MHH $8.09
- PLRX $1.64
- Analyst Decision
- MHH
- PLRX Hold
- Analyst Count
- MHH 0
- PLRX 10
- Target Price
- MHH N/A
- PLRX $3.93
- AVG Volume (30 Days)
- MHH 8.0K
- PLRX 984.8K
- Earning Date
- MHH 08-13-2025
- PLRX 08-07-2025
- Dividend Yield
- MHH N/A
- PLRX N/A
- EPS Growth
- MHH N/A
- PLRX N/A
- EPS
- MHH 0.07
- PLRX N/A
- Revenue
- MHH $200,000,000.00
- PLRX N/A
- Revenue This Year
- MHH N/A
- PLRX N/A
- Revenue Next Year
- MHH $4.52
- PLRX N/A
- P/E Ratio
- MHH $109.88
- PLRX N/A
- Revenue Growth
- MHH 5.16
- PLRX N/A
- 52 Week Low
- MHH $6.20
- PLRX $1.10
- 52 Week High
- MHH $16.00
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- MHH 61.77
- PLRX 56.62
- Support Level
- MHH $7.14
- PLRX $1.40
- Resistance Level
- MHH $8.09
- PLRX $1.70
- Average True Range (ATR)
- MHH 0.53
- PLRX 0.11
- MACD
- MHH 0.04
- PLRX 0.00
- Stochastic Oscillator
- MHH 94.06
- PLRX 77.78
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.